XML 146 R129.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jul. 31, 2022
Feb. 28, 2018
Stockholders Equity Note [Line Items]            
Net proceeds from issuance of common stock     $ 67,899,000 $ 20,248,000    
Share repurchases $ 23,694,000   $ 56,496,000      
Share Repurchase Program 2022            
Stockholders Equity Note [Line Items]            
Common stock authorized to repurchase by Board         $ 125,000,000  
Share repurchases (in shares) 3,400,000   7,100,000      
Available authorization remaining for repurchase $ 101,000,000   $ 101,000,000      
Prior Share Repurchase Program            
Stockholders Equity Note [Line Items]            
Common stock authorized to repurchase by Board           $ 100,000,000
Convertible Debt Securities            
Stockholders Equity Note [Line Items]            
Securities excluded in the calculation of diluted earnings per share (in shares) 49,137,808   37,307,705      
Equity awards            
Stockholders Equity Note [Line Items]            
Securities excluded in the calculation of diluted earnings per share (in shares) 249,178 22,102 268,737 18,736    
At The Market Offerings | Common Stock            
Stockholders Equity Note [Line Items]            
Issuance of common stock (in shares)     5,200,000      
Net proceeds from issuance of common stock     $ 67,000,000      
Remaining capacity $ 175,000,000   $ 175,000,000      
Direct Stock Purchases and Dividend Reinvestment Plan | Common Stock            
Stockholders Equity Note [Line Items]            
Shares remaining for future offerings 6,000,000   6,000,000      
Common Stock            
Stockholders Equity Note [Line Items]            
Issuance of common stock (in shares)   1,585,709 5,232,869 2,391,777    
Share repurchases (in shares) 3,448,858   7,128,891      
Share repurchases $ 35,000   $ 71,000